Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.44 |
| ▸ | CPA1 | P15085 | 1/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.40 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 3/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29462560 | 1.00 | MME (0.44) | MMEACECPA1ACE2PDCD1LG2 | |
| SCHEMBL29531322 | 0.96 | MME (0.47) | MMEACECPA1ACE2PDCD1LG2 | |
| SCHEMBL30781147 | 0.96 | MME (0.47) | MMEACECPA1ACE2PDCD1LG2 | |
| SCHEMBL5841678 | 0.96 | MME (0.47) | MMEACECPA1ACE2PDCD1LG2 | |
| SCHEMBL5841680 | 0.96 | MME (0.47) | MMEACECPA1ACE2PDCD1LG2 | |
| SCHEMBL23030200 | 0.96 | MME (0.47) | MMEACECPA1ACE2PDCD1LG2 | |
| SCHEMBL30792485 | 0.87 | PDCD1LG2 (0.42) | MMEPDCD1LG2CD274LTA4H | |
| SCHEMBL30552861 | 0.87 | MME (0.41) | MMEACECPA1ACE2PDCD1LG2 | |
| SCHEMBL29876890 | 0.87 | MME (0.47) | MMEACEPDCD1LG2CD274 | |
| SCHEMBL30552712 | 0.87 | MME (0.47) | MMEACEPDCD1LG2CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |